Lepisosteus oculatus isolate Spotted Gar 1 linkage group LG18, LepOcu1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Actinopterygii; Neopterygii; Holostei; Semionotiformes; Lepisosteidae; Lepisosteus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM001421.1.\nAssembly name: LepOcu1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Broad Institute on\n2012/01/13. The original whole-genome shotgun project has the\naccession AHAT00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Broad Institute\nAssembly Method :: AllPaths v. R38293\nAssembly Name :: LepOcu1\nGenome Coverage :: 677.5x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Version :: Lepisosteus oculatus Annotation\n Release 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 6.5\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
USA: Bayou Chevreuil, St. James Parish, Louisiana
Derived by automated computational analysis using gene prediction method: Gnomon.
Ral GTPase activating protein, beta subunit (non-catalytic), transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Ral GTPase activating protein, beta subunit (non-catalytic), transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Ral GTPase activating protein, beta subunit (non-catalytic), transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Ral GTPase activating protein, beta subunit (non-catalytic), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Ral GTPase activating protein, beta subunit (non-catalytic), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Ral GTPase activating protein, beta subunit (non-catalytic), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Ral GTPase activating protein, beta subunit (non-catalytic), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ral GTPase-activating protein subunit beta isoform X7
ral GTPase-activating protein subunit beta isoform X6
ral GTPase-activating protein subunit beta isoform X5
ral GTPase-activating protein subunit beta isoform X4
ral GTPase-activating protein subunit beta isoform X3
ral GTPase-activating protein subunit beta isoform X2
ral GTPase-activating protein subunit beta isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
TOX high mobility group box family member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
TOX high mobility group box family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
TOX high mobility group box family member 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
TOX high mobility group box family member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
TOX high mobility group box family member 2 isoform X1
TOX high mobility group box family member 2 isoform X2
TOX high mobility group box family member 2 isoform X5
TOX high mobility group box family member 2 isoform X3
TOX high mobility group box family member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TOX high mobility group box family member 2 isoform X4
large neutral amino acids transporter small subunit 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
core-binding factor, runt domain, alpha subunit 2; translocated to, 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
core-binding factor, runt domain, alpha subunit 2; translocated to, 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
core-binding factor, runt domain, alpha subunit 2; translocated to, 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
core-binding factor, runt domain, alpha subunit 2; translocated to, 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
core-binding factor, runt domain, alpha subunit 2; translocated to, 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
N-terminal EF-hand calcium binding protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
N-terminal EF-hand calcium binding protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
N-terminal EF-hand calcium binding protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
N-terminal EF-hand calcium-binding protein 3 isoform X1
N-terminal EF-hand calcium-binding protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
E3 ubiquitin-protein ligase Itchy homolog
zinc finger protein 341, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 341, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
zinc finger protein 341, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
protein-glutamine gamma-glutamyltransferase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
V-set and transmembrane domain containing 2 like
V-set and transmembrane domain-containing protein 2-like protein
TELO2 interacting protein 1, transcript variant X2
TELO2 interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X4
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X3
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X7
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X8
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X1
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X3
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X2
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X4
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X5
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X6
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
protein-glutamine gamma-glutamyltransferase 2
KIAA1755 ortholog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
KIAA1755 ortholog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
KIAA1755 ortholog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein KIAA1755 homolog isoform X2
uncharacterized protein KIAA1755 homolog isoform X3
uncharacterized protein KIAA1755 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
discs, large (Drosophila) homolog-associated protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
myosin regulatory light polypeptide 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 54 ESTs, 106 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
myosin regulatory light polypeptide 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 54 ESTs, 106 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
v-myb avian myeloblastosis viral oncogene homolog-like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC107079561, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC107079561 isoform X1
uncharacterized LOC107079561, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC107079561 isoform X2
intraflagellar transport 52, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
intraflagellar transport 52, transcript variant X2
intraflagellar transport protein 52 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
lethal(3)malignant brain tumor-like protein 1
serine/arginine-rich splicing factor 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
serine/arginine-rich splicing factor 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
serine/arginine-rich splicing factor 6 isoform X2
serine/arginine-rich splicing factor 6 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
band 4.1-like protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
band 4.1-like protein 1, transcript variant X2
band 4.1-like protein 1, transcript variant X4
band 4.1-like protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
band 4.1-like protein 1, transcript variant X6
band 4.1-like protein 1, transcript variant X3
band 4.1-like protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
band 4.1-like protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
band 4.1-like protein 1, transcript variant X9
band 4.1-like protein 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 1, transcript variant X1
CDK5 regulatory subunit associated protein 1, transcript variant X2
CDK5 regulatory subunit associated protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 1, transcript variant X4
CDK5 regulatory subunit associated protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
CDK5 regulatory subunit-associated protein 1 isoform X2
CDK5 regulatory subunit-associated protein 1 isoform X4
CDK5 regulatory subunit-associated protein 1 isoform X5
CDK5 regulatory subunit-associated protein 1 isoform X1
CDK5 regulatory subunit-associated protein 1 isoform X3
CDK5 regulatory subunit associated protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
CDK5 regulatory subunit-associated protein 1 isoform X6
BPI fold containing family B member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
BPI fold containing family B member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
BPI fold containing family B member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
phosphatidylinositol-3,4, 5-trisphosphate-dependent Rac exchange factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein
potassium channel, voltage gated KQT-like subfamily Q, member 2, transcript variant X10
potassium channel, voltage gated KQT-like subfamily Q, member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium channel, voltage gated KQT-like subfamily Q, member 2, transcript variant X4
potassium channel, voltage gated KQT-like subfamily Q, member 2, transcript variant X2
potassium channel, voltage gated KQT-like subfamily Q, member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium channel, voltage gated KQT-like subfamily Q, member 2, transcript variant X6
potassium channel, voltage gated KQT-like subfamily Q, member 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium channel, voltage gated KQT-like subfamily Q, member 2, transcript variant X7
potassium channel, voltage gated KQT-like subfamily Q, member 2, transcript variant X8
potassium channel, voltage gated KQT-like subfamily Q, member 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 2 isoform X1
potassium voltage-gated channel subfamily KQT member 2 isoform X6
potassium voltage-gated channel subfamily KQT member 2 isoform X2
potassium voltage-gated channel subfamily KQT member 2 isoform X7
potassium voltage-gated channel subfamily KQT member 2 isoform X3
potassium voltage-gated channel subfamily KQT member 2 isoform X8
potassium voltage-gated channel subfamily KQT member 2 isoform X5
potassium voltage-gated channel subfamily KQT member 2 isoform X9
potassium voltage-gated channel subfamily KQT member 2 isoform X4
potassium voltage-gated channel subfamily KQT member 2 isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
neuronal acetylcholine receptor subunit alpha-4
zinc finger, CCCH-type with G-patch domain, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
zinc finger, CCCH-type with G-patch domain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
zinc finger, CCCH-type with G-patch domain, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
zinc finger, CCCH-type with G-patch domain, transcript variant X2
zinc finger CCCH-type with G patch domain-containing protein
ADP ribosylation factor related protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
ADP-ribosylation factor-related protein 1
tumor necrosis factor receptor superfamily member 6b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
regulator of telomere elongation helicase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
glucocorticoid modulatory element binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
glucocorticoid modulatory element binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glucocorticoid modulatory element binding protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
glucocorticoid modulatory element-binding protein 2 isoform X1
glucocorticoid modulatory element-binding protein 2 isoform X2
glucocorticoid modulatory element-binding protein 2 isoform X3
helicase with zinc finger 2, transcriptional coactivator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
helicase with zinc finger 2, transcriptional coactivator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
helicase with zinc finger 2, transcriptional coactivator, transcript variant X3
WNT1 inducible signaling pathway protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
WNT1-inducible-signaling pathway protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
chromosome LG18 open reading frame, human C20orf195, transcript variant X1
chromosome LG18 open reading frame, human C20orf195, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chromosome LG18 open reading frame, human C20orf195, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromosome LG18 open reading frame, human C20orf195, transcript variant X4
uncharacterized protein C20orf195 homolog
uncharacterized LOC107079555, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC107079555, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein kinase 35-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
serine/threonine-protein kinase 35-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
helicase with zinc finger domain 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
helicase with zinc finger domain 2-like, transcript variant X3
helicase with zinc finger domain 2-like isoform X1
helicase with zinc finger domain 2-like isoform X3
helicase with zinc finger domain 2-like, transcript variant X2
helicase with zinc finger domain 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
protein kinase (cAMP-dependent, catalytic) inhibitor gamma, transcript variant X1
protein kinase (cAMP-dependent, catalytic) inhibitor gamma, transcript variant X2
protein kinase (cAMP-dependent, catalytic) inhibitor gamma, transcript variant X3
cAMP-dependent protein kinase inhibitor gamma
uncharacterized LOC107079560, transcript variant X2
uncharacterized LOC107079560, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC107079560 isoform X1
uncharacterized protein LOC107079560 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
tocopherol (alpha) transfer protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
tocopherol (alpha) transfer protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
alpha-tocopherol transfer protein-like isoform X1
alpha-tocopherol transfer protein-like isoform X2
uncharacterized LOC107079554, transcript variant X2
uncharacterized LOC107079554, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
R3H domain containing-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
R3H domain containing-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fat storage-inducing transmembrane protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
ganglioside induced differentiation associated protein 1-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ganglioside-induced differentiation-associated protein 1-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
thyrotropin-releasing hormone receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
osteoclast stimulatory transmembrane protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 13 member 3 isoform X1
solute carrier family 13 member 3 isoform X2
solute carrier family 13 member 3 isoform X3
CD276 antigen-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TP53 regulating kinase, transcript variant X2
TP53 regulating kinase, transcript variant X1
solute carrier family 2 (facilitated glucose transporter), member 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
solute carrier family 2 (facilitated glucose transporter), member 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC107079557, transcript variant X5
uncharacterized LOC107079557, transcript variant X4
uncharacterized LOC107079557, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC107079557, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC107079557, transcript variant X1
uncharacterized protein LOC107079557 isoform X4
uncharacterized protein LOC107079557 isoform X5
uncharacterized protein LOC107079557 isoform X1
uncharacterized LOC107079557, transcript variant X3
uncharacterized LOC107079557, transcript variant X2
uncharacterized protein LOC107079557 isoform X3
uncharacterized protein LOC107079557 isoform X2
CD83 antigen-like, transcript variant X2
CD83 antigen-like, transcript variant X1
casein kinase 2, alpha 1 polypeptide, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
casein kinase 2, alpha 1 polypeptide, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transcription factor 15 (basic helix-loop-helix), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transcription factor 15 (basic helix-loop-helix), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transcription factor 15 (basic helix-loop-helix), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 52 (riboflavin transporter), member 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 52 (riboflavin transporter), member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 52 (riboflavin transporter), member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
solute carrier family 52 (riboflavin transporter), member 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
solute carrier family 52 (riboflavin transporter), member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
solute carrier family 52 (riboflavin transporter), member 3, transcript variant X4
solute carrier family 52 (riboflavin transporter), member 3, transcript variant X5
solute carrier family 52 (riboflavin transporter), member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
solute carrier family 52 (riboflavin transporter), member 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 52, riboflavin transporter, member 3
ubiquitin-conjugating enzyme E2 variant 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 8 ESTs, 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
CCAAT/enhancer binding protein (C/EBP), beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine phosphatase, non-receptor type 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type 1
proto-oncogene tyrosine-protein kinase Src, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase Src, transcript variant X1
proto-oncogene tyrosine-protein kinase Src, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase Src, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase Src isoform X2
proto-oncogene tyrosine-protein kinase Src isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
potassium channel, voltage gated modifier subfamily G, member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
potassium channel, voltage gated modifier subfamily G, member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
potassium channel, voltage gated modifier subfamily G, member 1, transcript variant X4
potassium channel, voltage gated modifier subfamily G, member 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium channel, voltage gated modifier subfamily G, member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium channel, voltage gated modifier subfamily G, member 1, transcript variant X6
potassium voltage-gated channel subfamily G member 1
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
nuclear factor of activated T-cells, cytoplasmic 2 isoform X2
nuclear factor of activated T-cells, cytoplasmic 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
probable phospholipid-transporting ATPase IIA
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ZFP64 zinc finger protein, transcript variant X1
ZFP64 zinc finger protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ZFP64 zinc finger protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ZFP64 zinc finger protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
zinc finger protein 217, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
zinc finger protein 217, transcript variant X4
zinc finger protein 217, transcript variant X5
zinc finger protein 217, transcript variant X3
zinc finger protein 217, transcript variant X6
zinc finger protein 217, transcript variant X2
breast carcinoma amplified sequence 1, transcript variant X2
breast carcinoma amplified sequence 1, transcript variant X7
breast carcinoma amplified sequence 1, transcript variant X4
breast carcinoma amplified sequence 1, transcript variant X6
breast carcinoma amplified sequence 1, transcript variant X5
breast carcinoma amplified sequence 1, transcript variant X3
breast carcinoma amplified sequence 1, transcript variant X1
breast carcinoma-amplified sequence 1 isoform X2
breast carcinoma-amplified sequence 1 isoform X7
breast carcinoma-amplified sequence 1 isoform X4
breast carcinoma-amplified sequence 1 isoform X6
breast carcinoma-amplified sequence 1 isoform X5
breast carcinoma-amplified sequence 1 isoform X3
breast carcinoma-amplified sequence 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial, transcript variant X2
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
docking protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
docking protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
formin-like protein 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
formin-like protein 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 391-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 391-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
NFX1-type zinc finger-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
DEAD (Asp-Glu-Ala-Asp) box polypeptide 27
probable ATP-dependent RNA helicase DDX27
small nuclear ribonucleoprotein-associated protein B'
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
engulfment and cell motility 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
engulfment and cell motility 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
engulfment and cell motility 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
engulfment and cell motility 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
engulfment and cell motility 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
engulfment and cell motility 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
engulfment and cell motility 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
engulfment and cell motility 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
engulfment and cell motility protein 2 isoform X7
engulfment and cell motility protein 2 isoform X6
engulfment and cell motility protein 2 isoform X4
engulfment and cell motility protein 2 isoform X5
engulfment and cell motility protein 2 isoform X2
engulfment and cell motility protein 2 isoform X3
engulfment and cell motility protein 2 isoform X1
heat shock 70 kDa protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 29 ESTs, 244 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
heat shock 70 kDa protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 20 ESTs, 83 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
solute carrier family 35 (GDP-fucose transporter), member C2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
solute carrier family 35 (GDP-fucose transporter), member C2, transcript variant X1
solute carrier family 35 (GDP-fucose transporter), member C2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Sys1 golgi trafficking protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Sys1 golgi trafficking protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Sys1 golgi trafficking protein, transcript variant X4
Sys1 golgi trafficking protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Sys1 golgi trafficking protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Sys1 golgi trafficking protein, transcript variant X2
translocon-associated protein subunit alpha-like, transcript variant X2
translocon-associated protein subunit alpha-like, transcript variant X1
translocon-associated protein subunit alpha-like isoform X2
translocon-associated protein subunit alpha-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ADP ribosylation factor GTPase activating protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ADP ribosylation factor GTPase activating protein 1, transcript variant X3
ADP ribosylation factor GTPase activating protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ADP ribosylation factor GTPase activating protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ADP ribosylation factor GTPase activating protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ADP ribosylation factor GTPase activating protein 1, transcript variant X6
ADP ribosylation factor GTPase activating protein 1, transcript variant X7
ADP ribosylation factor GTPase activating protein 1, transcript variant X8
ADP-ribosylation factor GTPase-activating protein 1 isoform X1
ADP-ribosylation factor GTPase-activating protein 1 isoform X3
ADP-ribosylation factor GTPase-activating protein 1 isoform X4
ADP-ribosylation factor GTPase-activating protein 1 isoform X2
ADP-ribosylation factor GTPase-activating protein 1 isoform X5
ADP-ribosylation factor GTPase-activating protein 1 isoform X6
ADP-ribosylation factor GTPase-activating protein 1 isoform X7
ADP-ribosylation factor GTPase-activating protein 1 isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
collagen, type XX, alpha 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
collagen, type XX, alpha 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
collagen, type XX, alpha 1, transcript variant X4
collagen, type XX, alpha 1, transcript variant X1
DEP domain-containing mTOR-interacting protein-like, transcript variant X3
DEP domain-containing mTOR-interacting protein-like, transcript variant X2
DEP domain-containing mTOR-interacting protein-like, transcript variant X1
DEP domain-containing mTOR-interacting protein-like isoform X2
DEP domain-containing mTOR-interacting protein-like isoform X1
DEP domain-containing mTOR-interacting protein-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 83 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit
dolichol-phosphate mannosyltransferase subunit 1
activity-dependent neuroprotector homeobox, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
activity-dependent neuroprotector homeobox, transcript variant X1
activity-dependent neuroprotector homeobox protein
par-6 family cell polarity regulator beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ADP ribosylation factor guanine nucleotide exchange factor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
brefeldin A-inhibited guanine nucleotide-exchange protein 2
CSE1 chromosome segregation 1-like (yeast), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
CSE1 chromosome segregation 1-like (yeast), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
CSE1 chromosome segregation 1-like (yeast), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
staufen double-stranded RNA binding protein 1, transcript variant X1
staufen double-stranded RNA binding protein 1, transcript variant X3
staufen double-stranded RNA binding protein 1, transcript variant X2
double-stranded RNA-binding protein Staufen homolog 1 isoform X1
double-stranded RNA-binding protein Staufen homolog 1 isoform X2
somatomedin-B and thrombospondin type-1 domain-containing protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
somatomedin-B and thrombospondin type-1 domain-containing protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
somatomedin-B and thrombospondin type-1 domain-containing protein-like
potassium channel, voltage gated Shab related subfamily B, member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium voltage-gated channel subfamily B member 1
prostaglandin I2 (prostacyclin) synthase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
WAP four-disulfide core domain protein 3
phosphatidylinositol glycan anchor biosynthesis class T
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
phosphatase and actin regulator 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phosphatase and actin regulator 3, transcript variant X2
phosphatase and actin regulator 3 isoform X2
phosphatase and actin regulator 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phosphatase and actin regulator 3, transcript variant X1
phosphatase and actin regulator 3, transcript variant X3
phosphatase and actin regulator 3 isoform X1
phosphatase and actin regulator 3 isoform X3
phosphatase and actin regulator 3, transcript variant X4
phosphatase and actin regulator 3 isoform X4
phosphatase and actin regulator 3, transcript variant X7
phosphatase and actin regulator 3 isoform X5
synaptonemal complex protein 2, transcript variant X1
synaptonemal complex protein 2, transcript variant X2
protein phosphatase 1 regulatory subunit 3D, transcript variant X2
protein phosphatase 1 regulatory subunit 3D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 3D
family with sequence similarity 217 member B, transcript variant X3
family with sequence similarity 217 member B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
family with sequence similarity 217 member B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
family with sequence similarity 217 member B, transcript variant X6
family with sequence similarity 217 member B, transcript variant X1
family with sequence similarity 217 member B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
tubulin tyrosine ligase like 9, transcript variant X5
tubulin tyrosine ligase like 9, transcript variant X1
tubulin tyrosine ligase like 9, transcript variant X3
tubulin tyrosine ligase like 9, transcript variant X2
tubulin tyrosine ligase like 9, transcript variant X4
probable tubulin polyglutamylase TTLL9 isoform X4
probable tubulin polyglutamylase TTLL9 isoform X3
probable tubulin polyglutamylase TTLL9 isoform X2
probable tubulin polyglutamylase TTLL9 isoform X1
probable tubulin polyglutamylase TTLL9 isoform X5
uncharacterized LOC107079568, transcript variant X2
uncharacterized LOC107079568, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc finger protein 831, transcript variant X1
zinc finger protein 831, transcript variant X2
zinc finger protein 831, transcript variant X3
androgen-dependent TFPI-regulating protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
androgen-dependent TFPI-regulating protein-like, transcript variant X3
androgen-dependent TFPI-regulating protein-like, transcript variant X1
androgen-dependent TFPI-regulating protein-like isoform X1
androgen-dependent TFPI-regulating protein-like isoform X2
cleavage stimulation factor, 3' pre-RNA, subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Cas scaffolding protein family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cas scaffolding protein family member 4 isoform X2
Cas scaffolding protein family member 4, transcript variant X1
cas scaffolding protein family member 4 isoform X1
ribonucleic acid export 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ribonucleic acid export 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ribonucleic acid export 1, transcript variant X2
SPO11 meiotic protein covalently bound to DSB, transcript variant X2
SPO11 meiotic protein covalently bound to DSB, transcript variant X4
SPO11 meiotic protein covalently bound to DSB, transcript variant X3
SPO11 meiotic protein covalently bound to DSB, transcript variant X6
SPO11 meiotic protein covalently bound to DSB, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SPO11 meiotic protein covalently bound to DSB, transcript variant X7
SPO11 meiotic protein covalently bound to DSB, transcript variant X5
meiotic recombination protein SPO11 isoform X2
meiotic recombination protein SPO11 isoform X4
meiotic recombination protein SPO11 isoform X3
meiotic recombination protein SPO11 isoform X6
meiotic recombination protein SPO11 isoform X1
meiotic recombination protein SPO11 isoform X7
meiotic recombination protein SPO11 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC102691565, transcript variant X1
uncharacterized LOC102691565, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cadherin-like protein 26, transcript variant X2
cadherin-like protein 26, transcript variant X3
cadherin-like protein 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein SCO4629-like, transcript variant X1
uncharacterized protein SCO4629-like, transcript variant X3
uncharacterized protein SCO4629-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein SCO4629-like isoform X1
uncharacterized protein SCO4629-like isoform X2
mitochondrial ribosome-associated GTPase 2
synovial sarcoma translocation gene on chromosome 18-like 1, transcript variant X1
synovial sarcoma translocation gene on chromosome 18-like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
synovial sarcoma translocation gene on chromosome 18-like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium-responsive transactivator isoform X3
calcium-responsive transactivator isoform X1
calcium-responsive transactivator isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
LSM family member 14B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
LSM family member 14B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
TATA-box binding protein associated factor 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transcription initiation factor TFIID subunit 4
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA asparagine (anticodon GUU); tRNA features were annotated by tRNAscan-SE; Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cadherin 4, type 1, R-cadherin (retinal)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium channel subfamily K member 15-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transcription factor-like 5 (basic helix-loop-helix)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
death inducer-obliterator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
death inducer-obliterator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
death inducer-obliterator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
translocating chain-associated membrane protein 1-like 1
nuclear receptor coactivator 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
nuclear receptor coactivator 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
nuclear receptor coactivator 3, transcript variant X1
nuclear receptor coactivator 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nuclear receptor coactivator 3 isoform X2
nuclear receptor coactivator 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
extracellular sulfatase Sulf-2 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
extracellular sulfatase Sulf-2 isoform X3
extracellular sulfatase Sulf-2 isoform X2
extracellular sulfatase Sulf-2 isoform X1
eukaryotic translation elongation factor 1 alpha 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 153 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
MRG/MORF4L binding protein, transcript variant X1
MRG/MORF4L binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
histocompatibility (minor) 13, transcript variant X2
histocompatibility (minor) 13, transcript variant X1
histocompatibility (minor) 13, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
minor histocompatibility antigen H13 isoform X2
minor histocompatibility antigen H13 isoform X1
minor histocompatibility antigen H13 isoform X3
rho GTPase-activating protein 39-like, transcript variant X2
rho GTPase-activating protein 39-like, transcript variant X1
rho GTPase-activating protein 39-like isoform X1
rho GTPase-activating protein 39-like isoform X2
rho GTPase-activating protein 39-like, transcript variant X3
rho GTPase-activating protein 39-like isoform X3
PHD finger protein 20, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
PHD finger protein 20, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
PHD finger protein 20, transcript variant X4
PHD finger protein 20, transcript variant X5
PHD finger protein 20, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
PHD finger protein 20, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
NDRG family member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
NDRG family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
NDRG family member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NDRG family member 3, transcript variant X1
NDRG family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ER degradation enhancer, mannosidase alpha-like 2, transcript variant X3
ER degradation enhancer, mannosidase alpha-like 2, transcript variant X2
ER degradation-enhancing alpha-mannosidase-like protein 2 isoform X2
ER degradation enhancer, mannosidase alpha-like 2, transcript variant X1
ER degradation-enhancing alpha-mannosidase-like protein 2 isoform X1
ER degradation-enhancing alpha-mannosidase-like protein 2 isoform X3
transient receptor potential cation channel, subfamily C, member 4 associated protein
short transient receptor potential channel 4-associated protein
myosin, heavy chain 7B, cardiac muscle, beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
myosin, heavy chain 7B, cardiac muscle, beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
deoxynucleoside triphosphate triphosphohydrolase SAMHD1
deoxynucleoside triphosphate triphosphohydrolase SAMHD1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tumor protein p53 inducible nuclear protein 2, transcript variant X3
tumor protein p53 inducible nuclear protein 2, transcript variant X2
tumor protein p53 inducible nuclear protein 2, transcript variant X4
tumor protein p53 inducible nuclear protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
tumor protein p53 inducible nuclear protein 2, transcript variant X5
tumor protein p53-inducible nuclear protein 2 isoform X2
tumor protein p53-inducible nuclear protein 2 isoform X3
tumor protein p53-inducible nuclear protein 2 isoform X4
tumor protein p53-inducible nuclear protein 2 isoform X5
tumor protein p53 inducible nuclear protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
tumor protein p53-inducible nuclear protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase CYLD-like, transcript variant X2
ubiquitin carboxyl-terminal hydrolase CYLD-like, transcript variant X1
ubiquitin carboxyl-terminal hydrolase CYLD-like, transcript variant X3
ubiquitin carboxyl-terminal hydrolase CYLD-like, transcript variant X4
ubiquitin carboxyl-terminal hydrolase CYLD-like isoform X1
ubiquitin carboxyl-terminal hydrolase CYLD-like isoform X2
ubiquitin carboxyl-terminal hydrolase CYLD-like isoform X3
ubiquitin carboxyl-terminal hydrolase CYLD-like, transcript variant X5
ubiquitin carboxyl-terminal hydrolase CYLD-like, transcript variant X6
ubiquitin carboxyl-terminal hydrolase CYLD-like isoform X4
protein spire homolog 1-like, transcript variant X2
protein spire homolog 1-like, transcript variant X3
protein spire homolog 1-like, transcript variant X1
uncharacterized LOC107079575, transcript variant X2
uncharacterized LOC107079575, transcript variant X1
topoisomerase (DNA) I, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
topoisomerase (DNA) I, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
phospholipase C gamma 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phospholipase C gamma 1, transcript variant X2
phospholipase C gamma 1, transcript variant X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1
zinc fingers and homeoboxes 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc fingers and homeoboxes 3, transcript variant X1
chromosome LG18 open reading frame, human C20orf24
uncharacterized protein C20orf24 homolog
family with sequence similarity 83 member D
DEAH (Asp-Glu-Ala-His) box polypeptide 35
probable ATP-dependent RNA helicase DHX35
gastrula zinc finger protein XlCGF7.1-like, transcript variant X2
gastrula zinc finger protein XlCGF7.1-like, transcript variant X1
gastrula zinc finger protein XlCGF7.1-like
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ring finger protein 114, transcript variant X2
ring finger protein 114, transcript variant X1
E3 ubiquitin-protein ligase RNF114 isoform X2
E3 ubiquitin-protein ligase RNF114 isoform X1
spermatogenesis associated 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
spermatogenesis associated 2, transcript variant X4
spermatogenesis associated 2, transcript variant X3
spermatogenesis associated 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
elastin microfibril interfacer 3, transcript variant X1
elastin microfibril interfacer 3, transcript variant X2
AAR2 splicing factor homolog, transcript variant X4
AAR2 splicing factor homolog, transcript variant X1
AAR2 splicing factor homolog, transcript variant X2
AAR2 splicing factor homolog, transcript variant X3
sterile alpha motif domain containing 10, transcript variant X1
sterile alpha motif domain containing 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sterile alpha motif domain containing 10, transcript variant X2
sterile alpha motif domain containing 10, transcript variant X4
sterile alpha motif domain-containing protein 10 isoform X1
sterile alpha motif domain-containing protein 10 isoform X2
sterile alpha motif domain-containing protein 10 isoform X4
sterile alpha motif domain-containing protein 10 isoform X3
zinc finger protein 512B, transcript variant X2
zinc finger protein 512B, transcript variant X5
zinc finger protein 512B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 512B, transcript variant X4
zinc finger protein 512B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uridine-cytidine kinase 1-like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uridine-cytidine kinase 1-like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uridine-cytidine kinase-like 1 isoform X2
uridine-cytidine kinase-like 1 isoform X1
uridine-cytidine kinase 1-like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uridine-cytidine kinase 1-like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uridine-cytidine kinase-like 1 isoform X4
uridine-cytidine kinase-like 1 isoform X3
uncharacterized LOC107079569, transcript variant X2
uncharacterized LOC107079569, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
tripartite motif-containing protein 54-like, transcript variant X2
tripartite motif-containing protein 54-like, transcript variant X1
tripartite motif-containing protein 54-like, transcript variant X6
tripartite motif-containing protein 54-like isoform X2
tripartite motif-containing protein 54-like isoform X5
tripartite motif-containing protein 54-like isoform X1
tripartite motif-containing protein 54-like, transcript variant X3
tripartite motif-containing protein 54-like, transcript variant X7
tripartite motif-containing protein 54-like, transcript variant X5
tripartite motif-containing protein 54-like isoform X6
tripartite motif-containing protein 54-like isoform X3
tripartite motif-containing protein 54-like, transcript variant X4
tripartite motif-containing protein 54-like, transcript variant X8
tripartite motif-containing protein 54-like isoform X7
tripartite motif-containing protein 54-like isoform X4
dnaJ homolog subfamily C member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
dnaJ homolog subfamily C member 5, transcript variant X1
GID complex subunit 8, transcript variant X2
GID complex subunit 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
glucose-induced degradation protein 8 homolog isoform X1
glucose-induced degradation protein 8 homolog isoform X2
solute carrier family 17 (vesicular nucleotide transporter), member 9
basic helix-loop-helix family member e23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
class E basic helix-loop-helix protein 23
YTH N(6)-methyladenosine RNA binding protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
baculoviral IAP repeat containing 7, transcript variant X1
baculoviral IAP repeat containing 7, transcript variant X2
baculoviral IAP repeat-containing protein 7 isoform X1
baculoviral IAP repeat-containing protein 7 isoform X2
Na+/K+ transporting ATPase interacting 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Na+/K+ transporting ATPase interacting 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X3
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X1
Na+/K+ transporting ATPase interacting 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X2
uncharacterized LOC102685415, transcript variant X1
uncharacterized LOC102685415, transcript variant X3
uncharacterized LOC102685415, transcript variant X2
uncharacterized protein LOC102685415 isoform X1
uncharacterized LOC107079586, transcript variant X2
uncharacterized LOC107079586, transcript variant X1
uncharacterized protein LOC102685415 isoform X2
zinc finger protein 704-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
zinc finger protein 704-like, transcript variant X2
zinc finger and BTB domain containing 46, transcript variant X2
zinc finger and BTB domain-containing protein 46 isoform X2
zinc finger and BTB domain containing 46, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 46 isoform X1
tumor protein D52-like 2, transcript variant X4
tumor protein D52-like 2, transcript variant X1
tumor protein D52-like 2, transcript variant X2
tumor protein D52-like 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tumor protein D52-like 2, transcript variant X3
tumor protein D52-like 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
tumor protein D52-like 2, transcript variant X6
tumor protein D52-like 2, transcript variant X8
tumor protein D52-like 2, transcript variant X11
tumor protein D52-like 2, transcript variant X10
tumor protein D52-like 2, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
tumor protein D52-like 2, transcript variant X12
tumor protein D52-like 2, transcript variant X14
tumor protein D52-like 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transfer RNA glutamic acid (anticodon CUC); tRNA features were annotated by tRNAscan-SE; Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
pancreatic progenitor cell differentiation and proliferation factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X2
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X1
protein-L-isoaspartate O-methyltransferase domain-containing protein 2 isoform X2
protein-L-isoaspartate O-methyltransferase domain-containing protein 2 isoform X1
myelin transcription factor 1, transcript variant X6
myelin transcription factor 1, transcript variant X4
myelin transcription factor 1, transcript variant X11
myelin transcription factor 1, transcript variant X5
myelin transcription factor 1, transcript variant X3
myelin transcription factor 1, transcript variant X7
myelin transcription factor 1, transcript variant X2
myelin transcription factor 1, transcript variant X1
myelin transcription factor 1, transcript variant X10
myelin transcription factor 1, transcript variant X9
myelin transcription factor 1, transcript variant X8
myelin transcription factor 1 isoform X6
myelin transcription factor 1 isoform X4
myelin transcription factor 1 isoform X9
myelin transcription factor 1 isoform X5
myelin transcription factor 1 isoform X3
myelin transcription factor 1 isoform X7
myelin transcription factor 1 isoform X2
myelin transcription factor 1 isoform X1
myelin transcription factor 1 isoform X8
neuropeptides B/W receptor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
neuropeptides B/W receptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
opiate receptor-like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
opiate receptor-like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LKAAEAR motif containing 1, transcript variant X2
LKAAEAR motif containing 1, transcript variant X3
LKAAEAR motif containing 1, transcript variant X1
regulator of G-protein signaling 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
regulator of G-protein signaling 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
regulator of G-protein signaling 19, transcript variant X4
regulator of G-protein signaling 19 isoform X1
regulator of G-protein signaling 19 isoform X2
regulator of G-protein signaling 19, transcript variant X5
regulator of G-protein signaling 19, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
regulator of G-protein signaling 19, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
regulator of G-protein signaling 19 isoform X3
transcription elongation factor A (SII), 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
transcription elongation factor A protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cerebral cavernous malformation 2-like, transcript variant X2
cerebral cavernous malformation 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cerebral cavernous malformations 2 protein-like isoform X1
cerebral cavernous malformations 2 protein-like isoform X2
Cdk5 and Abl enzyme substrate 2, transcript variant X2
Cdk5 and Abl enzyme substrate 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
CDK5 and ABL1 enzyme substrate 2 isoform X1
CDK5 and ABL1 enzyme substrate 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
laminin subunit alpha 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
laminin subunit alpha 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
oxysterol binding protein like 2, transcript variant X6
oxysterol binding protein like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
oxysterol binding protein like 2, transcript variant X4
oxysterol binding protein like 2, transcript variant X1
oxysterol binding protein like 2, transcript variant X5
oxysterol binding protein like 2, transcript variant X2
oxysterol-binding protein-related protein 2
suppressor of glucose, autophagy associated 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
acyl-CoA synthetase short-chain family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
acyl-CoA synthetase short-chain family member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
acyl-CoA synthetase short-chain family member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
acyl-CoA synthetase short-chain family member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
acetyl-coenzyme A synthetase, cytoplasmic isoform X3
acetyl-coenzyme A synthetase, cytoplasmic isoform X2
acetyl-coenzyme A synthetase, cytoplasmic isoform X4
acetyl-coenzyme A synthetase, cytoplasmic isoform X1
EF-hand calcium binding domain 8, transcript variant X2
EF-hand calcium binding domain 8, transcript variant X1
EF-hand calcium-binding domain-containing protein 8 isoform X2
EF-hand calcium-binding domain-containing protein 8 isoform X1
EF-hand calcium binding domain 8, transcript variant X3
microtubule associated protein RP/EB family member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
microtubule-associated protein RP/EB family member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DNA (cytosine-5)-methyltransferase 3B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DNA (cytosine-5)-methyltransferase 3B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DNA (cytosine-5)-methyltransferase 3B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
DNA (cytosine-5)-methyltransferase 3B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DNA (cytosine-5)-methyltransferase 3B-like, transcript variant X4
DNA (cytosine-5)-methyltransferase 3B-like isoform X4
DNA (cytosine-5)-methyltransferase 3B-like isoform X1
DNA (cytosine-5)-methyltransferase 3B-like isoform X2
DNA (cytosine-5)-methyltransferase 3B-like isoform X3
COMM domain containing 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
COMM domain containing 7, transcript variant X1
COMM domain-containing protein 7 isoform X1
COMM domain-containing protein 7 isoform X2
nucleolar protein 4-like, transcript variant X1
nucleolar protein 4-like, transcript variant X2
nucleolar protein 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
additional sex combs like 1, transcriptional regulator, transcript variant X1
putative Polycomb group protein ASXL1 isoform X1
additional sex combs like 1, transcriptional regulator, transcript variant X2
putative Polycomb group protein ASXL1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
GDP-fucose protein O-fucosyltransferase 1
PLAG1 like zinc finger 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
PLAG1 like zinc finger 2, transcript variant X2
transmembrane 9 superfamily protein member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
HCK proto-oncogene, Src family tyrosine kinase, transcript variant X3
HCK proto-oncogene, Src family tyrosine kinase, transcript variant X1
HCK proto-oncogene, Src family tyrosine kinase, transcript variant X2
GATA binding protein 5, transcript variant X2
GATA binding protein 5, transcript variant X3
GATA binding protein 5, transcript variant X4
GATA binding protein 5, transcript variant X1
uncharacterized LOC107079592, transcript variant X2
uncharacterized LOC107079592, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC107079593, transcript variant X2
uncharacterized LOC107079593, transcript variant X1
uncharacterized LOC107079593, transcript variant X3
transfer RNA tyrosine (anticodon GUA); tRNA features were annotated by tRNAscan-SE; Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
solute carrier organic anion transporter family member 4A1, transcript variant X3
solute carrier organic anion transporter family member 4A1, transcript variant X9
solute carrier organic anion transporter family member 4A1, transcript variant X11
solute carrier organic anion transporter family member 4A1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
solute carrier organic anion transporter family member 4A1, transcript variant X10
solute carrier organic anion transporter family member 4A1, transcript variant X2
solute carrier organic anion transporter family member 4A1, transcript variant X5
solute carrier organic anion transporter family member 4A1, transcript variant X4
solute carrier organic anion transporter family member 4A1, transcript variant X6
solute carrier organic anion transporter family member 4A1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier organic anion transporter family member 4A1, transcript variant X7
solute carrier organic anion transporter family member 4A1 isoform X3
solute carrier organic anion transporter family member 4A1 isoform X1
solute carrier organic anion transporter family member 4A1 isoform X2
double-strand-break repair protein rad21-like protein 1, transcript variant X6
double-strand-break repair protein rad21-like protein 1, transcript variant X8
double-strand-break repair protein rad21-like protein 1, transcript variant X2
double-strand-break repair protein rad21-like protein 1, transcript variant X1
double-strand-break repair protein rad21-like protein 1, transcript variant X4
double-strand-break repair protein rad21-like protein 1, transcript variant X3
double-strand-break repair protein rad21-like protein 1, transcript variant X5
double-strand-break repair protein rad21-like protein 1, transcript variant X7
double-strand-break repair protein rad21-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase FKBP1A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
sodium-dependent lysophosphatidylcholine symporter 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
sodium-dependent lysophosphatidylcholine symporter 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sodium-dependent lysophosphatidylcholine symporter 1-like, transcript variant X2
sodium-dependent lysophosphatidylcholine symporter 1-like isoform X1
sodium-dependent lysophosphatidylcholine symporter 1-like isoform X2
sodium-dependent lysophosphatidylcholine symporter 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
cytochrome c oxidase subunit 4 isoform 2, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
myosin light chain kinase 2, skeletal/cardiac muscle
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
negative elongation factor complex member C/D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
GNAS complex locus, transcript variant X1
GNAS complex locus, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
guanine nucleotide-binding protein G(s) subunit alpha isoform X1
guanine nucleotide-binding protein G(s) subunit alpha isoform X2
uncharacterized LOC107079595, transcript variant X1
uncharacterized LOC107079595, transcript variant X2
piezo-type mechanosensitive ion channel component 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
tubulin beta 1 class VI, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 82 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
tubulin beta 1 class VI, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 139 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit
ATP synthase subunit epsilon, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 24 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 32 (GABA vesicular transporter), member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
vesicular inhibitory amino acid transporter
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
ARP5 actin-related protein 5 homolog (yeast)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 1 regulatory subunit 16B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein phosphatase 1 regulatory inhibitor subunit 16B
family with sequence similarity 210 member B
microtubule associated protein 1 light chain 3 alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
microtubule associated protein 1 light chain 3 alpha, transcript variant X2
microtubule-associated proteins 1A/1B light chain 3A isoform X1
microtubule-associated proteins 1A/1B light chain 3A isoform X2
dynein, light chain, roadblock-type 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
dynein, light chain, roadblock-type 1, transcript variant X1
dynein light chain roadblock-type 1 isoform X2
dynein light chain roadblock-type 1 isoform X1
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2, transcript variant X2
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 37% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sulfated surface glycoprotein 185-like
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like, transcript variant X1
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like, transcript variant X2
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like, transcript variant X3
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like, transcript variant X4
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like isoform X2
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like isoform X1
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like isoform X3
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
RNA binding motif protein 12, transcript variant X1
RNA binding motif protein 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 1, mitochondrial-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 1, mitochondrial-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 1, mitochondrial-like, transcript variant X4
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 1, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 1, mitochondrial-like
RNA binding motif protein 39, transcript variant X2
RNA binding motif protein 39, transcript variant X3
RNA binding motif protein 39, transcript variant X1
GTP-binding protein REM 1-like, transcript variant X1
GTP-binding protein REM 1-like, transcript variant X2
GTP-binding protein REM 1-like isoform X1
GTP-binding protein REM 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
GTP-binding protein REM 1-like isoform X2
GTP-binding protein REM 1-like, transcript variant X4
GTP-binding protein REM 1-like isoform X3
chromosome LG18 open reading frame, human C20orf96, transcript variant X1
chromosome LG18 open reading frame, human C20orf96, transcript variant X2
uncharacterized protein C20orf96 homolog
purine nucleoside phosphorylase-like, transcript variant X2
purine nucleoside phosphorylase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
purine nucleoside phosphorylase-like isoform X1
purine nucleoside phosphorylase-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
repressor of RNA polymerase III transcription MAF1 homolog
RanBP-type and C3HC4-type zinc finger containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
ranBP-type and C3HC4-type zinc finger-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase RNF182-like, transcript variant X1
E3 ubiquitin-protein ligase RNF182-like, transcript variant X2
regulator of G-protein signaling 9-binding protein-like, transcript variant X3
regulator of G-protein signaling 9-binding protein-like, transcript variant X2
regulator of G-protein signaling 9-binding protein-like, transcript variant X1
regulator of G-protein signaling 9-binding protein-like
ubiquitin conjugating enzyme E2C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ubiquitin conjugating enzyme E2C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
deoxynucleotidyltransferase, terminal, interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
deoxynucleotidyltransferase, terminal, interacting protein 1, transcript variant X1
deoxynucleotidyltransferase terminal-interacting protein 1
transfer RNA threonine (anticodon UGU); tRNA features were annotated by tRNAscan-SE; Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
PDX1 C-terminal inhibiting factor 1, transcript variant X2
PDX1 C-terminal inhibiting factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
PDX1 C-terminal inhibiting factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
phosphorylated CTD-interacting factor 1 isoform X2
phosphorylated CTD-interacting factor 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
neuralized E3 ubiquitin protein ligase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
neuralized E3 ubiquitin protein ligase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 12 (potassium/chloride transporter), member 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: matrix metalloproteinase-9
zinc finger protein 335, transcript variant X1
zinc finger protein 335, transcript variant X2
zinc finger protein 335, transcript variant X3
ankyrin repeat domain-containing protein SOWAHB-like, transcript variant X2
ankyrin repeat domain-containing protein SOWAHB-like, transcript variant X1
ankyrin repeat domain-containing protein SOWAHB-like isoform X1
ankyrin repeat domain-containing protein SOWAHC-like isoform X2
iroquois-class homeodomain protein IRX-5-like
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
replication termination factor 2 domain containing 1, transcript variant X2
replication termination factor 2 domain containing 1, transcript variant X1
glucosaminyl (N-acetyl) transferase family member 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glucosaminyl (N-acetyl) transferase family member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7 isoform X1
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7 isoform X2
adenomatosis polyposis coli down-regulated 1-like
VAMP (vesicle-associated membrane protein)-associated protein B and C
vesicle-associated membrane protein-associated protein B/C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X2
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X2
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X1
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X1
ankyrin repeat domain-containing protein 60
protein-glutamine gamma-glutamyltransferase E-like
cyclin D-type binding-protein 1, transcript variant X2
cyclin D-type binding-protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
phosphoenolpyruvate carboxykinase, cytosolic [GTP]
chromosome LG18 open reading frame, human C20orf85
uncharacterized protein C20orf85 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 35 ESTs, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
eukaryotic translation initiation factor 2 subunit beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
eukaryotic translation initiation factor 2 subunit beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
eukaryotic translation initiation factor 2 subunit 2 isoform X1
eukaryotic translation initiation factor 2 subunit 2 isoform X2
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X3
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X4
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X5
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X6
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X2
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X8
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
cytochrome c1, heme protein, mitochondrial
ERGIC and golgi 3, transcript variant X1
ERGIC and golgi 3, transcript variant X2
endoplasmic reticulum-Golgi intermediate compartment protein 3 isoform X1
endoplasmic reticulum-Golgi intermediate compartment protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC107079601, transcript variant X1
uncharacterized LOC107079601, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
oxidative stress induced growth inhibitor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
oxidative stress-induced growth inhibitor 1
phosphatidylinositol glycan anchor biosynthesis class U, transcript variant X1
phosphatidylinositol glycan anchor biosynthesis class U, transcript variant X2
phosphatidylinositol glycan anchor biosynthesis class U protein isoform X1
phosphatidylinositol glycan anchor biosynthesis class U protein isoform X2
uncharacterized LOC107079609, transcript variant X1
uncharacterized LOC107079609, transcript variant X2
protein tyrosine phosphatase, receptor type T, transcript variant X2
protein tyrosine phosphatase, receptor type T, transcript variant X4
protein tyrosine phosphatase, receptor type T, transcript variant X8
protein tyrosine phosphatase, receptor type T, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein tyrosine phosphatase, receptor type T, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein tyrosine phosphatase, receptor type T, transcript variant X7
protein tyrosine phosphatase, receptor type T, transcript variant X10
protein tyrosine phosphatase, receptor type T, transcript variant X11
protein tyrosine phosphatase, receptor type T, transcript variant X6
protein tyrosine phosphatase, receptor type T, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein tyrosine phosphatase, receptor type T, transcript variant X13
protein tyrosine phosphatase, receptor type T, transcript variant X12
protein tyrosine phosphatase, receptor type T, transcript variant X1
receptor-type tyrosine-protein phosphatase T isoform X1
receptor-type tyrosine-protein phosphatase T isoform X3
receptor-type tyrosine-protein phosphatase T isoform X7
receptor-type tyrosine-protein phosphatase T isoform X8
receptor-type tyrosine-protein phosphatase T isoform X10
receptor-type tyrosine-protein phosphatase T isoform X11
receptor-type tyrosine-protein phosphatase T isoform X2
receptor-type tyrosine-protein phosphatase T isoform X4
receptor-type tyrosine-protein phosphatase T isoform X5
receptor-type tyrosine-protein phosphatase T isoform X6
receptor-type tyrosine-protein phosphatase T isoform X12
receptor-type tyrosine-protein phosphatase T isoform X9
receptor-type tyrosine-protein phosphatase T isoform X13
uncharacterized LOC107079610, transcript variant X2
uncharacterized LOC107079610, transcript variant X1
uncharacterized LOC107079610, transcript variant X3
uncharacterized LOC107079591, transcript variant X2
uncharacterized LOC107079591, transcript variant X1
retinoblastoma-like 1, transcript variant X1
retinoblastoma-like protein 1 isoform X1
retinoblastoma-like 1, transcript variant X2
retinoblastoma-like protein 1 isoform X2
chromodomain helicase DNA binding protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 16 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
chromodomain-helicase-DNA-binding protein 6
family with sequence similarity 65 member C, transcript variant X2
family with sequence similarity 65 member C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
family with sequence similarity 65 member C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
actin-binding Rho-activating protein-like
regulating synaptic membrane exocytosis 4
regulating synaptic membrane exocytosis protein 4
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 219 ESTs, 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
embryonic polyadenylate-binding protein-like, transcript variant X4
embryonic polyadenylate-binding protein-like, transcript variant X3
embryonic polyadenylate-binding protein-like, transcript variant X2
embryonic polyadenylate-binding protein-like, transcript variant X1
embryonic polyadenylate-binding protein-like isoform X1
embryonic polyadenylate-binding protein-like isoform X2
translocase of outer mitochondrial membrane 34, transcript variant X2
translocase of outer mitochondrial membrane 34, transcript variant X1
mitochondrial import receptor subunit TOM34
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
potassium voltage-gated channel subfamily S member 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium voltage-gated channel subfamily S member 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily S member 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
recombination signal binding protein for immunoglobulin kappa J region-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
recombining binding protein suppressor of hairless-like protein
oxidative stress responsive serine-rich 1
oxidative stress-responsive serine-rich protein 1
uncharacterized LOC107079617, transcript variant X1
uncharacterized LOC107079617, transcript variant X2
ubiquinol-cytochrome-c reductase complex assembly factor 1
family with sequence similarity 83 member C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
eukaryotic translation initiation factor 6